reference/16136439

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/16136439

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	999
issn	1527-7755 0732-183X
issueIdentifier	9
pageRange	992-999
publicationName	Journal of clinical oncology : official journal of the American Society of Clinical Oncology
startingPage	992
bibliographicCitation	Mazières J, Zalcman G, Crinò L, Biondani P, Barlesi F, Filleron T, Dingemans AM, Léna H, Monnet I, Rothschild SI, Cappuzzo F, Besse B, Thiberville L, Rouvière D, Dziadziuszko R, Smit EF, Wolf J, Spirig C, Pecuchet N, Leenders F, Heuckmann JM, Diebold J, Milia JD, Thomas RK, Gautschi O. Crizotinib therapy for advanced lung adenocarcinoma and a ROS1 rearrangement: results from the EUROS1 cohort. J Clin Oncol. 2015 Mar 20;33(9):992–9. doi: 10.1200/jco.2014.58.3302. PMID: 25667280.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c5ea749bca98fc39a25353cd134fa1d3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5f9bdf99a35e79652c937542cde59968 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ed72b827f73b2543fd8e4218a620f05f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_db639711d598aad8b64d681f6c7af956 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_91b9565b0489f6168d8a5b71fd4158c7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d8f3d5d15b4cdf8796573c30223ecc7d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_516de4469d4b1dc182c51e705b128822 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_197e9aea0d239b7b5e2c5004a9a32c27 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_049d694e3d04f85107abb9d0caa71959 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-8080-9843 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f8166b24bf1c237822433ce24de2527f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2088a7bb2c0f62424af731525feef90b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7bdf88ffc1356238adfa467a1e3c4af0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7192bab7ddaca085f7a5e6e7e866df3e http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-6295-6767 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f6462ee57c55c635d734d78bb1360a68 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6a8f67936a5c41c5a533da5bd804011d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d5c60faf6742df217ae00d7a0543f499 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2b75680b47e8dedd74a90c22e3f1acde http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7d94461dc200cab1d8e796735f54e694 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3a50716647f6e732e68f1ec6014ab329 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1fbd794d9c34b984bfcb53ffb7c2787e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_becab233dcd7be025ab3c13b07edad73 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d83d3fc19d84dc67dad49c78d140ded4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-0724-0659 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9bd5af9b8c6487186a2cc8891978e7ed http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f5e5f2a01943ed1184ac52847619bb35 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cf81bedf3f8935cb1814e8ef2cc0338c
date	2015-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1200/jco.2014.58.3302 https://pubmed.ncbi.nlm.nih.gov/25667280
isPartOf	https://portal.issn.org/resource/ISSN/1527-7755 https://portal.issn.org/resource/ISSN/0732-183X http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5023
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Crizotinib Therapy for Advanced Lung Adenocarcinoma and a ROS1 Rearrangement: Results From the EUROS1 Cohort
discusses	http://id.nlm.nih.gov/mesh/M0172583 http://id.nlm.nih.gov/mesh/M0018233 http://id.nlm.nih.gov/mesh/M0018226 http://id.nlm.nih.gov/mesh/M0017909 http://id.nlm.nih.gov/mesh/M0457532 http://id.nlm.nih.gov/mesh/M0553416 http://id.nlm.nih.gov/mesh/M0017888
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D011518Q000235 http://id.nlm.nih.gov/mesh/D015321 http://id.nlm.nih.gov/mesh/D002289Q000188 http://id.nlm.nih.gov/mesh/D011505Q000235 http://id.nlm.nih.gov/mesh/D008175Q000188 http://id.nlm.nih.gov/mesh/D011725Q000627 http://id.nlm.nih.gov/mesh/D011720Q000627 http://id.nlm.nih.gov/mesh/D000230Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D005060 http://id.nlm.nih.gov/mesh/D018572 http://id.nlm.nih.gov/mesh/D012189 http://id.nlm.nih.gov/mesh/D018450 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D007150 http://id.nlm.nih.gov/mesh/D002289Q000235 http://id.nlm.nih.gov/mesh/D047428Q000627 http://id.nlm.nih.gov/mesh/D017404 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D014178 http://id.nlm.nih.gov/mesh/D000077547 http://id.nlm.nih.gov/mesh/D008175Q000235 http://id.nlm.nih.gov/mesh/D009154 http://id.nlm.nih.gov/mesh/D000230Q000235 http://id.nlm.nih.gov/mesh/D011446 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D056687
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135410875 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8366 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4e826c880e43b7ad8008a5acf74ab07b http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11626560 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23939 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11431 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6650

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6098

Total number of triples: 92.